Samsung Biologics secures first manufacturing base in U.S.
사진 확대 (Samsung Biologics)
Samsung Biologics Co. has expanded its global production network by securing its first manufacturing base in the United States.
Samsung Biologics announced on Wednesday that it completed the acquisition of a biopharmaceutical production facility in Rockville, Maryland, previously owned by GSK Plc, as of Tuesday, local time. The deal was carried out through its subsidiary, Samsung Biologics America.
The Rockville site is a drug substance (DS) manufacturing plant with total capacity of 60,000 liters, comprising two production buildings. It is equipped with infrastructure capable of producing antibody therapeutics at various scales, from clinical-stage to commercial production.
With this acquisition, Samsung Biologics has expanded its total production capacity to 845,000 liters from 785,000 liters. The company said that it has now established a dual production system connecting Songdo, Korea, and Rockville, enabling more stable and flexible supply to global clients.
In particular, securing a production base in North America is expected to strengthen responsiveness to local customers and further enhance competitiveness in winning global contracts.
Samsung Biologics has retained all approximately 500 employees at the Rockville facility, ensuring operational continuity. It plans to pursue stable supply of existing products while expanding new orders through integrated operations between the two production bases.
The company said it will also review further investment, including capacity expansion and technology upgrades at the Rockville facility, based on mid- to long-term demand and utilization.
“This represents a meaningful step in expanding our U.S. manufacturing footprint,” said John Rim, president and chief executive officer of Samsung Biologics. “The Rockville team brings deep expertise and strong operational experience that will further strengthen the site as part of our global manufacturing network.”
By Wang Hae-na and Chang Iou-chung
[ⓒ Pulse by Maeil Business News Korea & mk.co.kr, All rights reserved]
